Down-regulation of beta-catenin by activated p53.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Molecular and Cellular Biology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 11564862PMCID PMC99855
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• LDL-receptor-related protein 6 is a receptor for Dickkopf proteins

  2001cited by this paper
• Siah-1 mediates a novel beta-catenin degradation pathway linking p53 to the adenomatous polyposis coli protein.

  2001cited by this paper
• Siah-1, SIP, and Ebi collaborate in a novel pathway for beta-catenin degradation linked to p53 responses.

  2001cited by this paper
• Dickkopf-1, an inhibitor of the Wnt signaling pathway, is induced by p53

  2000cited by this paper
• Regulation of Lef-mediated Transcription and p53-dependent Pathway by Associating β-Catenin with CBP/p300*

  2000cited by this paper
• Regulation of beta-catenin signaling in the Wnt pathway.

  2000cited by this paper
• Differential interaction of plakoglobin and β-catenin with the ubiquitin-proteasome system

  2000cited by this paper
• Wnt signaling and cancer.

  2000cited by this paper
• The ARF/p53 pathway.

  2000cited by this paper
• WISP-1 is a Wnt-1- and beta-catenin-responsive oncogene.

  2000cited by this paper
• The p300/CBP acetyltransferases function as transcriptional coactivators of β‐catenin in vertebrates

  2000cited by this paper
• Differential Mechanisms of LEF/TCF Family-Dependent Transcriptional Activation by β-Catenin and Plakoglobin

  2000cited by this paper
• Plakoglobin and beta-catenin: protein interactions, regulation and biological roles.

  2000cited by this paper
• Activation of beta-catenin in epithelial and mesenchymal hepatoblastomas.

  2000cited by this paper
• Stress Signals Utilize Multiple Pathways To Stabilize p53

  2000cited by this paper
• Somatic mutations of beta-catenin play a crucial role in the tumorigenesis of sporadic hepatoblastoma.

  2000cited by this paper
• The transcriptional coactivator CBP interacts with beta-catenin to activate gene expression.

  2000cited by this paper
• Hepatocellular carcinoma in WHV/N-myc2 transgenic mice: oncogenic mutations of β-catenin and synergistic effect of p53 null alleles

  2000cited by this paper
• The F-box protein beta-TrCP associates with phosphorylated beta-catenin and regulates its activity in the cell.

  1999cited by this paper
• Regulation of the p53 Tumor Suppressor Protein*

  1999cited by this paper
• Exogenous Expression of β-Catenin Regulates Contact Inhibition, Anchorage-Independent Growth, Anoikis, and Radiation-Induced Cell Cycle Arrest

  1999cited by this paper
• The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway.

  1999cited by this paper
• Regulation of p53 stability

  1999cited by this paper
• Beta-catenin mutations are specific for colorectal carcinomas with microsatellite instability but occur in endometrial carcinomas irrespective of mutator pathway.

  1999cited by this paper
• The cellular response to p53: the decision between life and death

  1999cited by this paper
• The SCFbeta-TRCP-ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in IkappaBalpha and beta-catenin and stimulates IkappaBalpha ubiquitination in vitro.

  1999cited by this paper
• The metalloproteinase matrilysin is a target of β-catenin transactivation in intestinal tumors

  1999cited by this paper
• beta-catenin expression pattern in stage I and II ovarian carcinomas : relationship with beta-catenin gene mutations, clinicopathological features, and clinical outcome.

  1999cited by this paper
• A common human skin tumour is caused by activating mutations in beta-catenin.

  1999cited by this paper
• Transcriptional cross talk between NF-kappaB and p53.

  1999cited by this paper
• Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells.

  1999cited by this paper
• The Wnt/Wg Signal Transducer β-Catenin Controls Fibronectin Expression

  1999cited by this paper
• Childhood hepatoblastomas frequently carry a mutated degradation targeting box of the beta-catenin gene.

  1999cited by this paper
• An F‐box protein, FWD1, mediates ubiquitin‐dependent proteolysis of β‐catenin

  1999cited by this paper
• The dual role model for p53 in maintaining genomic integrity

  1999cited by this paper
• beta-Trcp couples beta-catenin phosphorylation-degradation and regulates Xenopus axis formation.

  1999cited by this paper
• Excess β‐catenin promotes accumulation of transcriptionally active p53

  1999cited by this paper
• Frequent mutation and nuclear localization of beta-catenin in anaplastic thyroid carcinoma.

  1999cited by this paper
• The oncogenic activation of beta-catenin.

  1999cited by this paper
• Proteolytic cleavage of beta-catenin by caspases: an in vitro analysis.

  1999cited by this paper
• Mutational activation of the beta-catenin proto-oncogene is a common event in the development of Wilms' tumors.

  1999cited by this paper
• Maintenance of genomic integrity by p53: complementary roles for activated and non-activated p53

  1999cited by this paper
• Sequence of molecular genetic events in colorectal tumorigenesis.

  1999cited by this paper
• Intestinal polyposis in mice with a dominant stable mutation of the β‐catenin gene

  1999cited by this paper
• The p53 pathway and apoptosis

  1999cited by this paper
• β‐Catenin mutation and expression analysis in ovarian cancer: Exon 3 mutations and nuclear translocation in 16% of endometrioid tumours

  1999cited by this paper
• TCF transcription factors: molecular switches in carcinogenesis.

  1999cited by this paper
• PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs.

  1999cited by this paper
• Target genes of beta-catenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas.

  1999cited by this paper
• HOS, a human homolog of Slimb, forms an SCF complex with Skp1 and Cullin1 and targets the phosphorylation-dependent degradation of IkappaB and beta-catenin.

  1999cited by this paper
• Regulation of p53 downstream genes.

  1998cited by this paper
• Frequent mutations in the beta-catenin gene in desmoid tumors from patients without familial adenomatous polyposis.

  1998cited by this paper
• Differential molecular interactions of beta-catenin and plakoglobin in adhesion, signaling and cancer.

  1998cited by this paper
• Viral Oncoproteins Discriminate between p53 and the p53 Homolog p73

  1998cited by this paper
• Inhibition of presenilin 1 expression is promoted by p53 and p21WAF-1 and results in apoptosis and tumor suppression

  1998cited by this paper
• Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer.

  1998cited by this paper
• Sporadic medulloblastomas contain oncogenic beta-catenin mutations.

  1998cited by this paper
• Differential Nuclear Translocation and Transactivation Potential of β-Catenin and Plakoglobin

  1998cited by this paper
• Reciprocal relationship between the tumor suppressors p53 and BAX in primary colorectal cancers

  1998cited by this paper
• Cytomechanics of cadherin-mediated cell-cell adhesion.

  1998cited by this paper
• Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas.

  1998cited by this paper
• Destabilization of β-catenin by mutations in presenilin-1 potentiates neuronal apoptosis

  1998cited by this paper
• De Novo hair follicle morphogenesis and hair tumors in mice expressing a truncated beta-catenin in skin.

  1998cited by this paper
• Beta-catenin mutation in carcinoma of the uterine endometrium.

  1998cited by this paper
• Beta-catenin mutations in human prostate cancer.

  1998cited by this paper
• Identification of c-MYC as a target of the APC pathway.

  1998cited by this paper
• Dismantling Cell–Cell Contacts during Apoptosis Is Coupled to a Caspase-dependent Proteolytic Cleavage of β-Catenin

  1997cited by this paper
• Armadillo coactivates transcription driven by the product of the Drosophila segment polarity gene dTCF.

  1997cited by this paper
• Beta-catenin as oncogene: the smoking gun.

  1997cited by this paper
• Recruitment of p300/CBP in p53-dependent signal pathways.

  1997cited by this paper
• Activation of β-Catenin-Tcf Signaling in Colon Cancer by Mutations in β-Catenin or APC

  1997cited by this paper
• Stabilization of beta-catenin by genetic defects in melanoma cell lines.

  1997cited by this paper
• Activation of Adenomatous Polyposis Coli (APC) Gene Expression by the DNA-alkylating AgentN-MethylN′-nitro-N-nitrosoguanidine Requires p53*

  1997cited by this paper
• Cell type‐specific inhibition of p53‐mediated apoptosis by mdm2.

  1996cited by this paper
• The axis-inducing activity, stability, and subcellular distribution of beta-catenin is regulated in Xenopus embryos by glycogen synthase kinase 3.

  1996cited by this paper
• Functional interaction of beta-catenin with the transcription factor LEF-1.

  1996cited by this paper
• XTcf-3 transcription factor mediates beta-catenin-induced axis formation in Xenopus embryos.

  1996cited by this paper
• Microinjection of monoclonal antibody PAb421 into human SW480 colorectal carcinoma cells restores the transcription activation function to mutant p53.

  1995cited by this paper
• Loss of Apc heterozygosity and abnormal tissue building in nascent intestinal polyps in mice carrying a truncated Apc gene.

  1995cited by this paper
• Regulation of intracellular beta-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein.

  1995cited by this paper
• WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis.

  1994cited by this paper
• Genetic changes of both p53 alleles associated with the conversion from colorectal adenoma to early carcinoma in familial adenomatous polyposis and non-familial adenomatous polyposis patients.

  1992cited by this paper
• An immunochemical analysis of the human nuclear phosphoprotein p53. New monoclonal antibodies and epitope mapping using recombinant p53.

  1992cited by this paper
• Inhibition of viral and cellular promoters by human wild-type p53

  1992cited by this paper
• Somatic mutations of the APC gene in colorectal tumors: mutation cluster region in the APC gene.

  1992cited by this paper
• Wild-type p53 can inhibit oncogene-mediated focus formation.

  1989cited by this paper
• Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas.

  1989cited by this paper
• Mutations in the p53 gene occur in diverse human tumour types

  1989cited by this paper
• Multiple genetic alterations in distal and proximal colorectal cancer.

  1989cited by this paper
• Isolation of human-p53-specific monoclonal antibodies and their use in the studies of human p53 expression.

  1986cited by this paper
• Monoclonal antibodies specific for simian virus 40 tumor antigens

  1981cited by this paper

• Exploring the oncogenic mechanism of plasmacytoma variant translocation 1 (PVT1) gene in solid cancers; emphasis on microRNA regulation pathways

  2026cites this paper
• Reciprocal and non-reciprocal effects of clinically relevant SETBP1 protein dosage changes

  2025cites this paper
• The Effect of Ionising Radiation on the Properties of Tumour-Derived Exosomes and Their Ability to Modify the Biology of Non-Irradiated Breast Cancer Cells—An In Vitro Study

  2025cites this paper
• ARID1A-driven modulation of EZH2 impedes proliferation and enhances senescence in breast cancer cells.

  2025cites this paper
• Organoselenocyanate-Conjugated NBDHEX Derivatives as Potent Anticancer Agents for the Treatment of Breast Cancer via ROS-Regulated Signaling Pathways.

  2025cites this paper
• Overview of Wnt/β-Catenin Pathway and DNA Damage/Repair in Cancer

  2025cites this paper
• PAR2 Serves an Indispensable Role in Controlling PAR4 Oncogenicity: The β-Catenin–p53 Axis

  2025cites this paper
• How can HPV E6 manipulate host cell differentiation process to maintain the reservoir of infection

  2025cites this paper
• Junction Plakoglobin – A Dual-Role Player in Cancer Biology

  2025cites this paper
• Unexpected links between cancer and telomere state.

  2025cites this paper
• Key signalling pathways in head and neck squamous cell carcinoma: mechanisms and therapeutic targets.

  2025cites this paper
• Therapeutic potential of flavonoids in gastrointestinal cancer: Focus on signaling pathways and improvement strategies (Review)

  2025cites this paper
• Inhibition of TBL1 cleavage alleviates doxorubicin-induced cardiomyocytes death by regulating the Wnt/β-catenin signal pathway

  2024cites this paper
• p53 inhibitor or antioxidants reduce the severity of ethmoid plate deformities in zebrafish Type 3 Treacher Collins syndrome model.

  2024cites this paper
• Cancer Mutations Converge on a Collection of Protein Assemblies to Predict Resistance to Replication Stress

  2024cites this paper
• The crosstalk of Wnt/β-catenin signaling and p53 in acute kidney injury and chronic kidney disease

  2024cites this paper
• TARDBP drives T‐cell acute lymphoblastic leukemia progression by binding MDM2 mRNA, involving β‐catenin pathway

  2024cites this paper
• Wnt signaling modulates the response to DNA damage in the Drosophila wing imaginal disc by regulating the EGFR pathway

  2024cites this paper
• Unraveling the chemotherapeutic potential of taxifolin ruthenium-p-cymene complex in breast carcinoma: Insights into AhR signaling pathway in vitro and in vivo

  2024cites this paper
• Suppression of Metastasis and Angiogenesis by Taxifolin Ruthenium-p-cymene Loaded PLGA Nanoparticles in Lung Carcinoma.

  2024cites this paper
• ZMIZ2 facilitates hepatocellular carcinoma progression via LEF1 mediated activation of Wnt/β-catenin pathway

  2024cites this paper
• GATA6 Amplification Is Associated With Improved Survival in TP53-Mutated Unresectable Pancreatic Cancer

  2024cites this paper
• β-catenin inhibitors in cancer therapeutics: intricacies and way forward

  2023cites this paper
• Pyrogallol promotes growth arrest by activating the p53‐mediated up‐regulation of p21 and p62/SQSTM1‐dependent degradation of β‐catenin in nonsmall cell lung cancer cells

  2023cites this paper
• The role of proteasomes in tumorigenesis

  2023cites this paper
• Multiple Actions of Telomerase Reverse Transcriptase in Cell Death Regulation

  2023cites this paper
• Estimation of genomic and mitochondrial DNA integrity in the renal tissue of mice administered with acrylamide and titanium dioxide nanoparticles

  2023cites this paper
• The possible role of Wnt/β‐catenin signalling in vitiligo treatment

  2023cites this paper
• Mitochondrial uncoupling induces epigenome remodeling and promotes differentiation in neuroblastoma.

  2022cites this paper
• Acquisition of taxane resistance by p53 inactivation in ovarian cancer cells

  2022cites this paper
• Cross-Talk between p53 and Wnt Signaling in Cancer

  2022cites this paper
• p53-Bad* Fusion Gene Therapy Induces Apoptosis In Vitro and Reduces Zebrafish Tumor Burden in Hepatocellular Carcinoma.

  2022cites this paper
• 1 Cell Permeable Stapled Peptide Inhibitor of Wnt Signaling that Targets β-Catenin Protein ‒ Protein Interactions

  2021cites this paper
• Crosstalk of the Wnt/β-Catenin Signaling Pathway in the Induction of Apoptosis on Cancer Cells

  2021cites this paper
• Bisphenol A-induced DNA damages promote to lymphoma progression in human lymphoblastoid cells through aberrant CTNNB1 signaling pathway

  2021cites this paper
• Adenomatous polyposis coli in cancer and therapeutic implications

  2021cites this paper
• Manuka honey enhanced sensitivity of HepG2, hepatocellular carcinoma cells, for Doxorubicin and induced apoptosis through inhibition of Wnt/β-catenin and ERK1/2

  2021cites this paper
• Lactobacillus rhamnosus confers protection against colorectal cancer in rats

  2021cites this paper
• Unravelling the roles of miRNAs in regulating epithelial-to-mesenchymal transition (EMT) in osteosarcoma.

  2021cites this paper
• DDX3X Loss is Associated with Aggressive Phenotypes in Non-Hodgkin’s Lymphomas

  2021cites this paper
• Signaling pathways in intestinal homeostasis and colorectal cancer: KRAS at centre stage

  2021cites this paper
• Pharmacological basis and new insights of taxifolin: A comprehensive review.

  2021cites this paper
• Clinical and mutational profiles of adult medulloblastoma groups

  2020cites this paper
• Absorption, metabolism, and bioactivity of vitexin: recent advances in understanding the efficacy of an important nutraceutical

  2020cites this paper
• The Role of p53-Mediated Signaling in the Therapeutic Response of Colorectal Cancer to 9F, a Spermine-Modified Naphthalene Diimide Derivative

  2020cites this paper
• Identification of potential therapeutic target of naringenin in breast cancer stem cells inhibition by bioinformatics and in vitro studies

  2020cites this paper
• Molecular implications of MUC5AC-CD44 axis in colorectal cancer progression and chemoresistance

  2020cites this paper
• WNT Signaling in Melanoma

  2020cites this paper
• A 3D Cell Culture Model Identifies Wnt/β‐Catenin Mediated Inhibition of p53 as a Critical Step during Human Hepatocyte Regeneration

  2020cites this paper
• Systematic analysis reveals a functional role for STAMBPL1 in the epithelial–mesenchymal transition process across multiple carcinomas

  2020cites this paper
• Reduction of squalene epoxidase by cholesterol accumulation accelerates colorectal cancer progression and metastasis.

  2020cites this paper
• Systematic analysis reveals a functional role for STAMBPL1 in the epithelial–mesenchymal transition process across multiple carcinomas

  2020cites this paper
• How does microRNA modulate Wnt/β-catenin signaling in thyroid oncogenesis?

  2020cites this paper
• Characterisation of resistance mechanisms developed by basal cell carcinoma cells in response to repeated cycles of Photodynamic Therapy

  2019cites this paper
• Paradoxical Role for Wild-Type p53 in Driving Therapy Resistance in Melanoma.

  2019cites this paper
• p53 and β-Catenin Expression Predict Poorer Prognosis in Patients With Anaplastic Large-Cell Lymphoma.

  2019cites this paper
• Varroa destructor parasitism has a greater effect on proteome changes than the deformed wing virus and activates TGF-β signaling pathways

  2019cites this paper
• β-Catenin: A Metazoan Filter for Biological Noise?

  2019cites this paper
• MicroRNA‐34a Promotes Endothelial Dysfunction and Mitochondrial‐mediated Apoptosis in Murine Models of Acute Lung Injury

  2019cites this paper
• Plakoglobin restores tumor suppressor activity of p53R175H mutant by sequestering the oncogenic potential of β‐catenin

  2018cites this paper
• Tp53 Mutation Inhibits Ubiquitination and Degradation of WISP1 via Down-Regulation of Siah1 in Pancreatic Carcinogenesis

  2018cites this paper
• MicroRNA-552 links Wnt signaling to p53 tumor suppressor in colorectal cancer.

  2018cites this paper
• Prostate tumor neuroendocrine differentiation via EMT: The road less traveled

  2018cites this paper
• Inhibiting β-Catenin by β-Carboline-Type MDM2 Inhibitor for Pancreatic Cancer Therapy

  2018cites this paper
• Inactivation of CK1α in multiple myeloma empowers drug cytotoxicity by affecting AKT and β-catenin survival signaling pathways

  2017cites this paper
• Functional Role of the COP9 Signalosome in Colorectal Cancer and Intestinal Homeostasis:Mechanistic Links to Cancerogenic Signaling Pathways in the Gut

  2017cites this paper
• Membrane-bound β-catenin degradation is enhanced by ETS2-mediated Siah1 induction in Helicobacter pylori-infected gastric cancer cells

  2017cites this paper
• Activation of EVI1 transcription by the LEF1/β-catenin complex with p53-alteration in myeloid blast crisis of chronic myeloid leukemia.

  2017cites this paper
• FZD8, a target of p53, promotes bone metastasis in prostate cancer by activating canonical Wnt/β-catenin signaling.

  2017cites this paper
• Cell Permeable Stapled Peptide Inhibitor of Wnt Signaling that Targets β-Catenin Protein-Protein Interactions.

  2017cites this paper
• Sirt1 Protects Endothelial Cells against LPS-Induced Barrier Dysfunction

  2017cites this paper
• Synergy between Prkdc and Trp53 regulates stem cell proliferation and GI-ARS after irradiation

  2017cites this paper
• The GSK3 kinase inhibitor lithium produces unexpected hyperphosphorylation of β-catenin, a GSK3 substrate, in human glioblastoma cells

  2017cites this paper
• Nuclear α-catenin mediates the DNA damage response via β-catenin and nuclear actin

  2017cites this paper
• Function of translationally controlled tumor protein (TCTP) in Eudrilus eugeniae regeneration

  2017cites this paper
• Beta-catenin and p53 expression in topographic compartments of colorectal cancer and its prognostic value following surgery.

  2017cites this paper
• p 53 and Medulloblastoma

  2016cites this paper
• Lactobacillus rhamnosus induced epithelial cell apoptosis, ameliorates inflammation and prevents colon cancer development in an animal model.

  2016cites this paper
• Molecular Genetics of Intracranial Meningiomas with Emphasis on Canonical Wnt Signalling

  2016cites this paper
• Loss of p53 expression is accompanied by upregulation of beta‐catenin in meningiomas: a concomitant reciprocal expression

  2016influential citation
• AXIN1 Expression and Localization in Meningiomas and Association to Changes of APC and E-cadherin.

  2016cites this paper
• p53 and Meduloblastoma.

  2016cites this paper
• GSK-3β-mediated fatty acid synthesis enhances epithelial to mesenchymal transition of TLR4-activated colorectal cancer cells through regulation of TAp63.

  2016cites this paper
• Class III-specific HDAC inhibitor Tenovin-6 induces apoptosis, suppresses migration and eliminates cancer stem cells in uveal melanoma

  2016cites this paper
• Ursolic acid inhibits proliferation and induces apoptosis by inactivating Wnt/β-catenin signaling in human osteosarcoma cells.

  2016cites this paper
• Identification des régulateurs de l’expression transcriptionnelle de TSPAN8 impliqués dans l’invasion précoce du mélanome cutané

  2016cites this paper
• Effects of mutations in Wnt/β-catenin, hedgehog, Notch and PI3K pathways on GSK-3 activity-Diverse effects on cell growth, metabolism and cancer.

  2016cites this paper
• Tenovin-6-mediated inhibition of SIRT1/2 induces apoptosis in acute lymphoblastic leukemia (ALL) cells and eliminates ALL stem/progenitor cells

  2015cites this paper
• ESEA: Discovering the Dysregulated Pathways based on Edge Set Enrichment Analysis

  2015cites this paper
• Beryllium is a potent and unique GSK-3β inhibitor with potential to differentially regulate glycogen synthase and β-catenin

  2015cites this paper
• Downregulation of Meg3 enhances cisplatin resistance of lung cancer cells through activation of the WNT/β-catenin signaling pathway.

  2015cites this paper
• RETRACTED: Shikonin Inhibits the Migration and Invasion of Human Glioblastoma Cells by Targeting Phosphorylated β-Catenin and Phosphorylated PI3K/Akt: A Potential Mechanism for the Anti-Glioma Efficacy of a Traditional Chinese Herbal Medicine

  2015cites this paper
• Ekspresija gena za beta-katenin i p53 u meningeomima

  2015cites this paper
• Crosstalk between Wnt/β-catenin and Hedgehog/Gli signaling pathways in colon cancer and implications for therapy

  2015cites this paper
• Effect of TP53 16-bp and β-TrCP 9-bp INS/DEL polymorphisms in relation to risk of breast cancer.

  2015cites this paper
• p21WAF1/Cip1 limits senescence and acinar‐to‐ductal metaplasia formation during pancreatitis

  2015cites this paper
• p53 Protein Regulates Hsp90 ATPase Activity and Thereby Wnt Signaling by Modulating Aha1 Expression*

  2014cites this paper
• Transcription factor KLF9 suppresses the growth of hepatocellular carcinoma cells in vivo and positively regulates p53 expression.

  2014cites this paper
• Wnt inhibitory factor 1 suppresses cancer stemness and induces cellular senescence

  2014cites this paper
• Involvement of β-catenin in matrine-induced autophagy and apoptosis in WB-F344 cells.

  2014cites this paper